The Breast Cancer Patient Congress Brought Scientists and Patients Together in an Important Social Responsibility Project! 1

The “Breast Cancer Patient Congress,” aiming to give patients direct access to current international cancer information, took place in Antalya on 28-29 June.
Organized jointly by Uludağ University, Pittsburg University and Antalya Breast Diseases Association, it featured distinguished specialist scientists. Patients diagnosed with breast cancer, receiving or having completed treatment, and their families attended, obtaining current information and asking speakers questions answered firsthand.
Opening the first day, Memorial Health Group Antalya Oncology Group and Antalya Breast Diseases Association President Prof. Dr. Mustafa Özdoğan said: “We are delighted to open this meeting, perhaps Türkiye's first bringing scientists and breast cancer patients together. We hope such meetings multiply. In the information age, everyone wants correct information. Early diagnosis and treatment change rapidly; scientists discuss developments but inadequately reach society. Together with nongovernmental organizations, we aimed to make this information more shareable and created this congress.” It began with a scientific session in Pamukkale on Friday, 27 June. “Over 200 physical medicine specialists, medical oncologists, surgeons, radiation oncologists, physiotherapists, psychologists and psychiatrists joined a multidisciplinary program. Approximately 63 academics informed over 200 physicians. An important course on lymphedema, led by University of Pittsburg breast surgeon Prof. Dr. Atilla Soran, offered highly satisfactory information sharing.”
He said the 28-29 June congress would last 2 days, beginning with breast cancer, prevention and early diagnosis. The second day would cover developments worldwide and in Türkiye, inaccessible or different technologies, local treatments, psychosocial issues and sexual problems and solutions after treatment. He concluded with news of a Kıraç concert after the first day.
Reports containing information presented by our valued specialists will be published on our website in 5 parts. Follow them in the “cancer news” section.
Let us examine the first-day highlights of this valuable awareness congress..
University of Pittsburg breast surgeon Prof. Dr. Atilla Soran moderated the 1st panel, “Getting to Know Breast Cancer.” Calling it an important cancer, he thanked Prof. Dr. Mustafa Özdoğan, Akdeniz University surgeon Prof. Dr. Cumhur Arıcı and Antalya Breast Diseases Association for bringing experts and patients together.
American Hospital Medical Oncology Professor Dr. Sevil Bavbek detailed breast structure, cancer, symptoms and treatment, noting pain is uncommon. The aim is detection before life-threatening size and preferably before palpability. “Diagnostic methods assess estrogen- and progesterone-sensitive, HER2-positive or hormone-insensitive tumors and help decide medication. Even aggressive HER2-positive tumors now have treatments. Calling a cell merely breast cancer under the microscope is insufficient; we examine its molecular structure.”
Early-stage treatment includes protective therapy against recurrence; advanced treatment aims to improve quality of life, relieve symptoms and prolong survival. “Protective treatment for advanced breast cancer must consider side-effect risk, age, menopause, health, nodes, aggressiveness, estrogen, progesterone or HER 2 pathways and tumor genetics to personalize treatment.” She concluded: “Together we are stronger and want to remain upright like a tree.”
Second speaker Istanbul University surgeon Prof. Dr. Vahit Özmen reviewed breast cancer globally and locally. “Our grandparents once died at 60; now the age is 80. In Bahçeşehir, %20 of women were very overweight. Women work, care for families and face partner and life stress. Smoking has increased, with lung cancer now first in incidence and breast cancer second. Poor diet also contributes.” WHO data showed in 2012, 14 million cancers worldwide; projections for 2030 indicate % 50 more patients and 13 million deaths. “Heart disease leads mortality now, but in 2030 cancer will lead, with ¾ of deaths in developing countries like Türkiye, because prevention is better in developed countries.” Istanbul University and the Cancer Control Association found a rise over the last 20 years exceeding %200. Western lifestyles mean later marriage and childbirth, shorter breastfeeding, obesity and longer life. A study in 2013 found that women over 40 at a rate of %80 had mammography. Awareness through calls and meetings helps, as in America. He recommended self-examination, yearly mammography after 40 and annual gynecological examination.
Delayed treatment partly reflects doubts about Turkish doctors' equipment and expertise, and rural women not consulting because lumps are painless. “Specialists in major cities follow global developments and adapt quickly. Painlessness does not rule out cancer; only %8-10 of breast cancers cause pain. Incidence declines in the West but increases in Türkiye. Our younger population develops younger disease, sometimes with larger, more advanced tumors. Clinical research is insufficient. Screening begins at 40 because of our young population. More screening requires awareness and more meetings. Government support for universities should help eliminate treatment delays.”
Citing America as a developed country taking preventive measures, Prof. Dr. Atilla Soran said every woman over 40 receives a system invitation and a phone message if possible, encouraging health checkups. Nongovernmental organizations support uninsured women too. He emphasized preventive measures and 4 influential risk factors: “Preventing a body mass index above 30, meaning excess weight, and avoiding inactivity by walking at least 5 days weekly for ½ hour protect against cancer and recurrence in those already affected. Limiting alcohol to no more than 2 glasses weekly, and addressing advancing age, especially after 40, through annual mammography and regular medical checks can protect against breast cancer death.” He stressed that regular checks enable early diagnosis, and early-stage breast cancer carries almost no threat to life.
Third speaker Akdeniz University surgeon Prof. Dr. Cumhur Arıcı discussed early diagnosis. Despite rising incidence, deaths decline because of early detection and treatment advances. Older age, being female, prolonged estrogen exposure through early menstruation and late menopause, and inherited genetics are risk factors.
“Early diagnosis increases the chance of breast-conserving surgery. When diagnosed early, patients' 5-year survival exceeds %95. Self-examination, routine medical checks and mammography screening are important. Self-examination helps women know their breast tissue and notice changes earlier,” Prof. Arıcı continued. “Because individual risk factors differ, checkup frequency varies with the level of risk. Research shows starting screening at 40 is important for early diagnosis.” Addressing concerns about mammography harms, he said: “Approximately 1 million mammograms trigger 1 cancer, while every 100 detect 1. Its benefit is therefore 10.000 times its harm, and the radiation dose equals approximately 9-10 hours of air travel.”
“Cancer itself is actually a genetic disease!”
Final speaker Bursa Uludağ University Head of Medical Oncology Prof. Dr. Ender Kurt distinguished familial from hereditary breast cancer. Relatives of affected people have greater familial risk; hereditary disease involves a detected genetic defect passed through generations. “Faulty inherited genes confer varying risk, from both mother and father.” Genetically originating cancers account for %5-10. Different cancers cluster in families without always identifiable causes. “Cancer itself is genetic.” He explained genes, bodily mechanisms and inherited defects, noting that a faulty P53, called a “bodyguard protecting genetic structure” by American scientists, makes cancer cell formation certain alongside other defects. Breast and ovarian cancers are the commonest inherited cancers; BRCA and P53 are major genes. Male breast cancer in an uncle or brother prompts family testing, and cancer across generations informs risk. Detected defects lead to medication, surgery or frequent screening. At age 25, tests should avoid radiation, which could raise risk. Removing both breasts in BRCA or P53 defects does not reduce risk by %100 but lowers it by %95-98. “Risk never becomes zero, but can decrease substantially.”
Prof. Mustafa Özdoğan moderated the second panel of treated patients sharing experiences. Speaker and physician Günseli Akaydın moved everyone by sharing experiences, feelings and perspectives after breast and then colon cancer diagnoses.
Second speaker, journalist Nevval Sevindi, shared her experience confronting cancer. Continuing her support association's work and attending international panels, she urged patients to stand firm, question and not abandon life. She described fighting two cancers at different times; participants followed appreciatively.
Final speaker Füsun Önen emphasized nongovernmental organizations' role, describing their efforts to raise awareness and reach as many people as possible, with or without cancer.
The first day ended with an art exhibition and opening reception.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.